Source:http://linkedlifedata.com/resource/pubmed/id/11112115
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-1-24
|
pubmed:abstractText |
Severity criteria for community-acquired pneumonia (CAP) have always excluded patients with human immunodeficiency virus (HIV) infection. A 1-yr, multicenter, prospective observational study of HIV-infected patients with bacterial CAP was done to validate the criteria used in the American Thoracic Society (ATS) guidelines for CAP, and to determine the prognosis-associated factors in the HIV-infected population with bacterial CAP. Overall, 355 cases were included, with an attributable mortality of 9.3%. Patients who met the ATS criteria had a longer hospital stay (p = 0.01), longer duration of fever (p < 0.001), and higher attributable mortality (13.1% versus 3.5%, p = 0.02) than those who did not. Three factors were independently related to mortality: CD4(+) cell count < 100/microl, radiologic progression of disease, and shock. Pleural effusion, cavities, and/or multilobar infiltrates at admission were independently associated with radiologic progression. A prognostic rule based on the five criteria of shock, CD4(+) cell count < 100/microl, pleural effusion, cavities, and multilobar infiltrates had a high negative predictive value for mortality (97.1%). The attributable mortality for severe pneumonia was 11.3%, as compared with 1.3% for nonsevere disease (p = 0.008). The ATS severity criteria are valid in HIV-infected patients with bacterial CAP. Our study provides the basis for identification of patients who may require hospitalization determined by clinical judgment and the five clinical criteria of shock, a CD4(+) cell count < 100/microl, pleural effusion, cavities, and multilobar involvement. These prognostic factors should be validated in independent cohort studies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1073-449X
|
pubmed:author |
pubmed-author:AliagaLL,
pubmed-author:BarreraAA,
pubmed-author:ColladoAA,
pubmed-author:CorderoEE,
pubmed-author:Gómez-MateosJJ,
pubmed-author:GirónJ AJA,
pubmed-author:González-SerranoMM,
pubmed-author:Hernández-QueroJJ,
pubmed-author:MerinoM DMD,
pubmed-author:NuñoEE,
pubmed-author:PachónJJ,
pubmed-author:RiveroAA,
pubmed-author:Torres-TortosaMM
|
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2063-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11112115-AIDS-Related Opportunistic Infections,
pubmed-meshheading:11112115-Adult,
pubmed-meshheading:11112115-Analysis of Variance,
pubmed-meshheading:11112115-Chi-Square Distribution,
pubmed-meshheading:11112115-Community-Acquired Infections,
pubmed-meshheading:11112115-Female,
pubmed-meshheading:11112115-HIV-1,
pubmed-meshheading:11112115-Humans,
pubmed-meshheading:11112115-Logistic Models,
pubmed-meshheading:11112115-Male,
pubmed-meshheading:11112115-Pneumonia, Bacterial,
pubmed-meshheading:11112115-Prognosis,
pubmed-meshheading:11112115-Prospective Studies,
pubmed-meshheading:11112115-Reproducibility of Results,
pubmed-meshheading:11112115-Severity of Illness Index,
pubmed-meshheading:11112115-Spain
|
pubmed:year |
2000
|
pubmed:articleTitle |
Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.
|
pubmed:affiliation |
Infectious Diseases Services, Virgen del Rocío University Hospital, Seville, Spain. mcordero@cica.es
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|